Related Experiment Video
Updated: Nov 15, 2025
07:31
A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
Published on: May 3, 2021
4.0K
PTHR1 in osteosarcoma: Specific molecular mechanisms and comprehensive functional perspective
Chaonan Sun1, Shenglong Li2,3
1Department of Radiation Oncology, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, Shenyang, China.
Journal of Cellular and Molecular Medicine
|March 6, 2021
Summary
Parathyroid hormone receptor 1 (PTHR1) is highly expressed in osteosarcoma, a bone cancer affecting children and adolescents. Targeting PTHR1 may offer new therapeutic strategies for this aggressive cancer.
Area of Science:
- Oncology
- Molecular Biology
- Bone Cancer Research
Background:
- Osteosarcoma is the most common primary bone malignancy in children and adolescents.
- Despite treatment advances, high recurrence and metastasis rates persist, necessitating new therapeutic targets.
- Parathyroid hormone receptor 1 (PTHR1) is implicated in osteosarcoma progression.
Purpose of the Study:
- To review the role of PTHR1 in osteosarcoma pathogenesis.
- To assess PTHR1 as a potential diagnostic biomarker.
- To explore therapeutic strategies targeting PTHR1.
Main Methods:
- Literature review of recent research on PTHR1 in osteosarcoma.
- Analysis of PTHR1 expression patterns and correlations.
- Evaluation of PTHR1's role in epigenetic and transcriptional regulation.
Main Results:
- Elevated PTHR1 expression in osteosarcoma tissues correlates with aggressive behavior and poor prognosis.
- PTHR1 expression is linked to epigenetic, transcriptional, post-translational, and protein interaction mechanisms.
- PTHR1 is a significant factor in osteosarcoma progression.
Conclusions:
- PTHR1 plays a critical role in osteosarcoma progression.
- PTHR1 shows potential as a novel biomarker for osteosarcoma.
- Targeting PTHR1 presents promising therapeutic avenues for osteosarcoma treatment.
Related Concept Videos
03:03mTOR Signaling and Cancer Progression
4.0K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.0K
02:23Abnormal Proliferation
4.9K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.9K
01:22PI3K/mTOR/AKT Signaling Pathway
4.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
4.6K
01:17Hormones and Bone Tissue
3.3K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
3.3K
01:31Osteoclasts in Bone Remodeling
3.5K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.5K
02:57Targeted Cancer Therapies
8.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.1K